NASDAQ:MCRB

Seres Therapeutics Stock News

etoro logo Buy MCRB
*Your capital is at risk
$4.83
+0.0500 (+1.05%)
At Close: Jul 31, 2026
Para a gestora Ibiuna, economia entra em uma terceira fase da crise, com menos riscos do que antes. Clique aqui para ler mais sobre.
The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (
CDI announces that Cyrus Lam has been promoted to Chief Financial Officer (CFO), now responsible for the Company's overall financial operations.
GAN Limited (the “Company” or “GAN”) (NASDAQ: GAN), a leading business-to-business supplier of internet gambling software-as-a-service solutions to th
Petites ou grandes, elles ont su dépasser la crise, voire parfois en profiter. Dans la foulée, elles prévoient des dizaines de milliers de créations de postes., En ces temps de plans sociaux et d
Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) announced today its decision to run the 146th Kentucky Derby on September 5, 2020 without fans. CDI issued
Upgrades * Wedbush upgraded the previous rating for Best Buy Co Inc (NYSE: BBY) from Neutral to Outperform. For the first quarter, Best Buy Co had an EPS of $0.67, compared to year-ago quarter EPS o
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade, as investors are awaiting earnings from Walmart Inc (NYSE: WMT), Advance Auto Parts, Inc. (...
Seres Therapeutics, Inc. today announced the closing of an underwritten public offering of 12,075,000 shares of its common stock.

Why Seres Therapeutics Stock Surged Today

10:31pm, Thursday, 13'th Aug 2020
What happened Shares of Seres Therapeutics (NASDAQ: MCRB) jumped 21% on Thursday after the biotech company announced the details of its capital raise.  So what Seres will sell 10.5 million shares fo
Evogene Ltd. has developed a unique Computational Predictive Biology platform, leveraging big data and artificial intelligence to life-science products such as microbes, small molecules and genes.
Seres Therapeutics, Inc. today announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock.
To say Seres Therapeutics (MCRB) began the week with a bang would be a severe understatement. More like an earth-shattering explosion. Shares surged by 390% in Monday’s trading after the microbiome
Seres Therapeutics, Inc. today announced that it is commencing an underwritten registered public offering of 8,000,000 shares of its common stock.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE